These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34315233)

  • 21. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.
    Zeymer U; Parhofer KG; Pittrow D; Binz C; Schwertfeger M; Limbourg T; Röther J
    Clin Res Cardiol; 2009 Apr; 98(4):249-56. PubMed ID: 19221687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Andersen P; Kragholm K; Torp-Pedersen C; Jensen SE; Attar R
    Int J Cardiol; 2021 Nov; 343():131-137. PubMed ID: 34499974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
    Melgaard L; Gorst-Rasmussen A; Rasmussen LH; Lip GY; Larsen TB
    PLoS One; 2016; 11(3):e0152269. PubMed ID: 27015524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention.
    Hart O; Xue N; Khashram M
    ANZ J Surg; 2023 Oct; 93(10):2376-2381. PubMed ID: 37370242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study.
    Blinc A; Kozak M; Sabovic M; Božic M; Stegnar M; Poredoš P; Kravos A; Barbic-Žagar B; Pohar Perme M; Stare J;
    Int Angiol; 2011 Dec; 30(6):555-66. PubMed ID: 22233617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review of guidelines on peripheral artery disease screening.
    Ferket BS; Spronk S; Colkesen EB; Hunink MG
    Am J Med; 2012 Feb; 125(2):198-208.e3. PubMed ID: 22079018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B; Henriksson M; Lundin F; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016.
    Kamil S; Sehested TSG; Houlind K; Lassen JF; Gislason GH; Dominguez H
    Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):142-149. PubMed ID: 35580585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of guideline-directed medical therapy on 5-year mortality in patients with newly diagnosed peripheral artery disease.
    Lee JH; Jeon HS; Lee JW; Youn YJ; Ahn SG; Kim H; Bae Y; Kim U; Ahn CM; Ko YG
    J Vasc Surg; 2023 Dec; 78(6):1471-1478.e3. PubMed ID: 37597591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
    Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
    JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends in characteristics and outcomes after myocardial infarction in patients with and without peripheral artery disease - A Nationwide, register-based follow-up study.
    Andersen PJ; Attar R; Jensen SE; Eftekhari A; Polcwiartek C; Søndergaard MM; Pareek M; Torp-Pedersen C; Kragholm K
    Int J Cardiol; 2024 Apr; 401():131812. PubMed ID: 38280530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.
    Cea-Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    BMJ Open; 2018 Jan; 8(1):e018184. PubMed ID: 29358428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal trends in abdominal aortic aneurysmal disease: a nationwide cohort study on cardiovascular morbidity and medical cardioprotective therapy.
    Nicolajsen CW; Søgaard M; Eldrup N; Jensen M; Larsen TB; Goldhaber SZ; Nielsen PB
    Eur J Prev Cardiol; 2022 Nov; 29(15):1957-1964. PubMed ID: 35670082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Goto S; Ohman EM; Elbez Y; Sritara P; Baumgartner I; Banerjee S; Creager MA; Bhatt DL;
    Eur Heart J; 2014 Nov; 35(41):2864-72. PubMed ID: 24585266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
    Hackam DG; Tan MK; Lin PJ; Mehta PG; Jaffer S; Kates M; Oh M; Grima EA; Langer A; Goodman SG; ;
    J Vasc Surg; 2006 Oct; 44(4):776-81. PubMed ID: 16930931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials.
    Bauersachs R; Wu O; Briere JB; Bowrin K; Borkowska K; Jakubowska A; Taieb V; Toumi M; Huelsebeck M
    Cardiovasc Ther; 2020; 2020():3057168. PubMed ID: 32695228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.